Nebenwirkungsmanagement Bei Der Behandlung Mit Bevacizumab Plus Interferon Alfa-2a
Best Practice Onkologie - Germany
doi 10.1007/bf03359734
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2010
Authors
Publisher
Springer Science and Business Media LLC